324 related articles for article (PubMed ID: 37492721)
1. Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
Deng L; Liang P; Cui H
Genes Dis; 2023 Sep; 10(5):1937-1955. PubMed ID: 37492721
[TBL] [Abstract][Full Text] [Related]
2. Selective transduction of astrocytic and neuronal CNS subpopulations by lentiviral vectors pseudotyped with Chikungunya virus envelope.
Eleftheriadou I; Dieringer M; Poh XY; Sanchez-Garrido J; Gao Y; Sgourou A; Simmons LE; Mazarakis ND
Biomaterials; 2017 Apr; 123():1-14. PubMed ID: 28152379
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy.
Gutierrez-Guerrero A; Cosset FL; Verhoeyen E
Viruses; 2020 Sep; 12(9):. PubMed ID: 32933033
[TBL] [Abstract][Full Text] [Related]
4. Generation of High-Titer Pseudotyped Lentiviral Vectors.
Hu S; Li M; Akkina R
Methods Mol Biol; 2019; 1937():125-134. PubMed ID: 30706393
[TBL] [Abstract][Full Text] [Related]
5. Pseudotyped Lentiviral Vectors: One Vector, Many Guises.
Joglekar AV; Sandoval S
Hum Gene Ther Methods; 2017 Dec; 28(6):291-301. PubMed ID: 28870117
[TBL] [Abstract][Full Text] [Related]
6. Optimized Pre-Clinical Grade Production of Two Novel Lentiviral Vector Pseudotypes for Lung Gene Delivery.
Rosales Gerpe MC; van Lieshout LP; Domm JM; van Vloten JP; Datu J; Ingrao JC; Yu DL; de Jong J; Moraes TJ; Krell PJ; Bridle BW; Wootton SK
Hum Gene Ther; 2020 Apr; 31(7-8):459-471. PubMed ID: 32000531
[TBL] [Abstract][Full Text] [Related]
7. Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein.
Carpentier DC; Vevis K; Trabalza A; Georgiadis C; Ellison SM; Asfahani RI; Mazarakis ND
Gene Ther; 2012 Jul; 19(7):761-74. PubMed ID: 21900965
[TBL] [Abstract][Full Text] [Related]
8. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
9. Systemic delivery of CRISPR/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector.
Lee S; Kim YY; Ahn HJ
Biomaterials; 2021 May; 272():120793. PubMed ID: 33836291
[TBL] [Abstract][Full Text] [Related]
10. A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein.
Kato S; Kobayashi K; Inoue K; Kuramochi M; Okada T; Yaginuma H; Morimoto K; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2011 Feb; 22(2):197-206. PubMed ID: 20954846
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.
Schauber CA; Tuerk MJ; Pacheco CD; Escarpe PA; Veres G
Gene Ther; 2004 Feb; 11(3):266-75. PubMed ID: 14737086
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent.
Janssens W; Chuah MK; Naldini L; Follenzi A; Collen D; Saint-Remy JM; VandenDriessche T
Hum Gene Ther; 2003 Feb; 14(3):263-76. PubMed ID: 12639306
[TBL] [Abstract][Full Text] [Related]
13. Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein.
Sakuma T; De Ravin SS; Tonne JM; Thatava T; Ohmine S; Takeuchi Y; Malech HL; Ikeda Y
Hum Gene Ther; 2010 Dec; 21(12):1665-73. PubMed ID: 20507233
[TBL] [Abstract][Full Text] [Related]
14. Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes.
Tomás HA; Mestre DA; Rodrigues AF; Guerreiro MR; Carrondo MJT; Coroadinha AS
Mol Ther Methods Clin Dev; 2019 Dec; 15():1-8. PubMed ID: 31528654
[TBL] [Abstract][Full Text] [Related]
15. Design and construction of a recombinant lentiviral vector with specific tropism to human epidermal growth factor-overexpressed cancer cells: Developing a new retargeting system for lentivirus vectors.
Ebrahimabadi S; Shahbazi M; Akbari M; Golalipour M; Farazmandfar T
J Gene Med; 2019 Jun; 21(6):e3095. PubMed ID: 31050357
[TBL] [Abstract][Full Text] [Related]
16. Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.
Huszthy PC; Giroglou T; Tsinkalovsky O; Euskirchen P; Skaftnesmo KO; Bjerkvig R; von Laer D; Miletic H
PLoS One; 2009 Jul; 4(7):e6314. PubMed ID: 19617915
[TBL] [Abstract][Full Text] [Related]
17. Enhanced central nervous system transduction with lentiviral vectors pseudotyped with RVG/HIV-1gp41 chimeric envelope glycoproteins.
Trabalza A; Eleftheriadou I; Sgourou A; Liao TY; Patsali P; Lee H; Mazarakis ND
J Virol; 2014 Mar; 88(5):2877-90. PubMed ID: 24371049
[TBL] [Abstract][Full Text] [Related]
18. Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment.
Bender RR; Muth A; Schneider IC; Friedel T; Hartmann J; Plückthun A; Maisner A; Buchholz CJ
PLoS Pathog; 2016 Jun; 12(6):e1005641. PubMed ID: 27281338
[TBL] [Abstract][Full Text] [Related]
19. Pseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization.
Zhang C; Hu B; Xiao L; Liu Y; Wang P
Hum Gene Ther Methods; 2014 Dec; 25(6):328-38. PubMed ID: 25416034
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in lentiviral vectors for gene therapy.
Wang X; Ma C; Rodríguez Labrada R; Qin Z; Xu T; He Z; Wei Y
Sci China Life Sci; 2021 Nov; 64(11):1842-1857. PubMed ID: 34708326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
